Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
[Treatment of hyperlipidemia with bezafibrate].
1986
D Yeshurun, and L Landman, and A Lanir, and M Aviram, and J Brook
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
D006949
Hyperlipidemias
Conditions with excess LIPIDS in the blood.
Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D006801
Humans
Members of the species Homo sapiens.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001629
Bezafibrate
An antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW DENSITY LIPOPROTEINS and increases HIGH DENSITY LIPOPROTEINS.
Azufibrat,BM-15.075,Befibrat,Beza-Lande,Beza-Puren,Bezabeta,Bezacur,Bezafibrat PB,Bezafisal,Bezalip,Bezamerck,Béfizal,Cedur,Difaterol,Eulitop,Lipox,Reducterol,Regadrin B,Sklerofibrat,Solibay,durabezur,BM 15.075,BM15.075,Beza Lande,Beza Puren
Related Publications
D Yeshurun, and L Landman, and A Lanir, and M Aviram, and J Brook
Bezafibrate in the treatment of hyperlipidemia.
February 1989, Boletin de la Asociacion Medica de Puerto Rico,
D Yeshurun, and L Landman, and A Lanir, and M Aviram, and J Brook
Therapy of Canine Hyperlipidemia with Bezafibrate.
May 2017, Journal of veterinary internal medicine,
D Yeshurun, and L Landman, and A Lanir, and M Aviram, and J Brook
[Effectiveness of bezafibrate in ambulatory treatment of hyperlipidemia].
September 1983, Polski tygodnik lekarski (Warsaw, Poland : 1960),
D Yeshurun, and L Landman, and A Lanir, and M Aviram, and J Brook
[Effects of bezafibrate in patients with combined hyperlipidemia].
February 1986, Medicina clinica,
D Yeshurun, and L Landman, and A Lanir, and M Aviram, and J Brook
Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination.
January 1993, Clinical therapeutics,
D Yeshurun, and L Landman, and A Lanir, and M Aviram, and J Brook
[Therapeutic effects of bezafibrate in hyperlipidemia].
May 1983, Casopis lekaru ceskych,
D Yeshurun, and L Landman, and A Lanir, and M Aviram, and J Brook
[Bezafibrate and delayed action etofibrate in hyperlipidemia].
February 1983, Deutsche medizinische Wochenschrift (1946),
D Yeshurun, and L Landman, and A Lanir, and M Aviram, and J Brook
[Effect of bezafibrate on the carbohydrate metabolism of 17 diabetics with hyperlipidemia].
February 1981, Die Medizinische Welt,
D Yeshurun, and L Landman, and A Lanir, and M Aviram, and J Brook
A therapeutic trial of bezafibrate on patients with hyperlipidemia with or without diabetes mellitus.
July 1984, Proceedings of the National Science Council, Republic of China. Part B, Life sciences,
D Yeshurun, and L Landman, and A Lanir, and M Aviram, and J Brook
[Carbohydrate metabolism in bezafibrate therapy. Controlled study of glibenclamide-treated diabetics with hyperlipidemia].
May 1982, MMW, Munchener medizinische Wochenschrift,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name